Microbiology & Diagnostics

客户信息covid-19

您的Bruker微生物学和诊断团队在Covid-19危机期间可以为您做什么

Thank you

在布鲁克(Bruker),我们一直紧随Covid-19大流行的演变。我们每天都会阅读和学习医疗保健提供者如何竭尽所能支持患者,了解病毒的流行病学和传播。

We are very grateful for those extraordinary efforts.

我们意识到,在当前的关键环境中,您的Bruker产品的功能良好和支持至关重要。

Digital meetings

We’re pleased to provide a solution for virtual face-to-face meetings with your Bruker Microbiology & Diagnostics team. We are all here to listen, support and address your needs.

您的Bruker微生物学和诊断团队可以与您组织数字会议,无论是为使用Bruker产品提供支持,还是讨论其他产品以提高您的功能。Read more

On-site service of your Bruker Microbiology & Diagnostics systems

Bruker strives to continue service operations as much as possible under the respective framework set by local authorities.

As many regions and countries implemented travel restrictions, that only allow emergency travel, we are forced to reduce our service operations to urgent maintenance and repair visits for

  • equipment that is used in clinical labs or related to the clinical treatment of patients
  • 设备对人造成伤害的风险或任何other significant damage, if not maintained in short term.

Bruker commits to pay special attention to your and our employees’ health and safety. Therefore, we aim on servicing your Bruker system under increased safety conditions. Prior to every service visit we kindly ask you to confirm this by signing a letter.Download the letter.

SARS-CoV-2 diagnostics

  • Rapid and specific detection of two independent SARS-CoV-2 targets by the new FluoroType® SARS-CoV-2 plus IVD-CE real-time PCR kit, in less than two hours.Read more
  • In need of recombinant SARS-CoV-2 antigens for developing COVID-19 in vitro diagnostics?Read more

Save precious time

  • When every minute counts for your critical ICU patients, by using the Sepsityper® solution for direct pathogen identification from positive blood culture bottles within 15-20 minutes.Read more

  • For your lab staff, by replacing steel MALDI targets by disposable ones:

Supply of Bruker Microbiology & Diagnostics CARE consumables

We continue production and shipping of the CARE consumables necessary to run your MALDI Biotyper® / IR Biotyper® / AST / molecular diagnostics applications. We do not anticipate interruptions in the short term, but nevertheless we kindly encourage you to fill your stock, as a careful precaution taking into account the currently unpredictable situation with COVID-19.Read more

Take care and stay healthy!

您的布鲁克微生物学和诊断团队

More information

Banner_Covid

COVID-19 Related Diagnostics

COVID-19 may be accompanied by a secondary bacterial or viral infection in the immunocompromised individual. Rapid diagnosis is critical to determine the correct course of treatment.
laboratory

Supporting Microbiology Labs

COVID-19 may be accompanied by a secondary bacterial or viral infection, which must also be diagnosed and managed. Bruker's MALDI Biotyper® is already in place at the labs which have served and will continue to support increased demand. These systems can manage high volumes of testing for any secondary bacterial infection.
sepsis-and-resistance-testing-banner-bruker

Sepsis

As well as needing tests for the virus itself, patients who are critically ill with COVID-19 are susceptible to secondary bacterial infections and require appropriate testing and treatment. An additional risk for these vulnerable patients is the development of sepsis.
861991888

Antimicrobial susceptibility testing

尽管需要进行更多的研究来研究Covid-19,次生细菌感染和死亡率之间的联系,但很明显,抗菌素易感性测试(AST)将需要在COVID-19患者的治疗计划中发挥至关重要的作用。通过快速建立细菌的耐药性,临床医生可以提供最合适的抗生素来尽快对抗感染。
bruker-mycobacteria

Mycobacteria

TB primarily affects the lungs, so in light of the recent coronavirus pandemic, efforts are being made to understand how TB patients might be affected by co-infection with SARS-CoV-2.
bruker-hiv-virus

艾滋病病毒

Laboratories already equipped with the HIV / Hepatitis B (HBV) Charge Virale assay from Biocentric, normally used to quantify viral load in patient samples, can switch their operation directly to COVID-19 testing. The test for COVID-19 follows the same protocols as the HIV/HBV viral load test and can be easily switched to be up and running within a day, with no need for additional training or workflow changes and validation.
450853983

COVID-19 and fungal co-infections

As the SARS-CoV-2 virus, which causes COVID-19, continues to take hold across the globe, a significant risk to patients is that the primary infection can be complicated by secondary infection which may be bacterial or fungal.